000			02069 a2200529 4500
005			20250514025431.0
264		0	_c20020506
008			200205s 0 0 eng d
022			_a1528-4042
024	7		_a10.1007/s11910-001-0016-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aSinger, H S
245	0	0	_aThe treatment of tics. _h[electronic resource]
260			_bCurrent neurology and neuroscience reports _cMar 2001
300			_a195-202 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdrenergic alpha-Agonists _xtherapeutic use
650	0	4	_aAndrogen Antagonists _xtherapeutic use
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aAntipsychotic Agents _xtherapeutic use
650	0	4	_aAutoimmune Diseases _xetiology
650	0	4	_aBotulinum Toxins, Type A _xtherapeutic use
650	0	4	_aCannabinoids _xtherapeutic use
650	0	4	_aClinical Trials as Topic
650	0	4	_aCross-Over Studies
650	0	4	_aDopamine Agonists _xtherapeutic use
650	0	4	_aDopamine Antagonists _xtherapeutic use
650	0	4	_aDouble-Blind Method
650	0	4	_aGABA-A Receptor Agonists
650	0	4	_aGonadal Steroid Hormones _xphysiology
650	0	4	_aHumans
650	0	4	_aImmunoglobulins, Intravenous _xtherapeutic use
650	0	4	_aNeurosurgical Procedures
650	0	4	_aNicotine _xtherapeutic use
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aReceptors, Dopamine _xdrug effects
650	0	4	_aReceptors, Nicotinic _xdrug effects
650	0	4	_aReceptors, Serotonin _xdrug effects
650	0	4	_aSerotonin Antagonists _xtherapeutic use
650	0	4	_aSerotonin Receptor Agonists _xtherapeutic use
650	0	4	_aStreptococcal Infections _xcomplications
650	0	4	_aTics _xdrug therapy
650	0	4	_aTourette Syndrome _xcomplications
650	0	4	_agamma-Aminobutyric Acid _xphysiology
773	0		_tCurrent neurology and neuroscience reports _gvol. 1 _gno. 2 _gp. 195-202
856	4	0	_uhttps://doi.org/10.1007/s11910-001-0016-8 _zAvailable from publisher's website
999			_c11804536 _d11804536